Experimental Goodpasture's syndrome in Wistar-Kyoto rats immunized with α3 chain of type IV collagen

Kidney International

Volumn 54, Issue 5, 1998, Pages 1550-1561

  Abbate, Mauro ^b   Kalluri, Raghuram ^a   Corna, Daniela ^c   Yamaguchi, Naoto ^c   Mccluskey, Robert T ^c   Hudson, Billy G ^c   Andres, Giuseppe ^c   Zoja, Carla ^c   Remuzzi, Giuseppe ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MARIO NEGRI INST PHARMACOL RES   (Italy)

^c NONE

Author keywords

Anti GBM disease; Dendritic cell; Extracellular matrix; GBM 3(IV) NC1 peptide; Glomerulonephritis; Lung hemorrhage; Thymocyte

Indexed keywords

COLLAGEN TYPE 4; DIMER; EPITOPE; IMMUNOGLOBULIN G; MONOMER; POLYMER; SYNTHETIC PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLOMERULONEPHRITIS; GLOMERULUS BASEMENT MEMBRANE; GOODPASTURE SYNDROME; IMMUNIZATION; IMMUNOGLOBULIN DEPOSITION; IMMUNOHISTOLOGY; IMMUNOLOGICAL TOLERANCE; INOCULATION; LUNG HEMORRHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; THYMUS;

EID: 0031758530     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00153.x     Document Type: Article

References (56)

1. STREBLAY RW: Anti-glomeular basement membrane glomerulonephritis. Am J Pathol 96:875-878, 1979
2. SADO Y, OKIGAKI T, TAKAMIYA H, SENO S; Experimental autoimmune glomerulonephritis with pulmonary hemorrhage in rats. The dose-effect relationship of the nephritogenic antigen from bovine glomerular basement membrane. J Clin Lab Immunol 15:199-204, 1984
3. SADO Y, NAITO I, AKITA M, OKIGAKI T: Strain specific responses of inbred rats on the severity of experimental autoimmune glomerulonephritis. J Clin Lab Immunol 19:193-199, 1986
4. SADO Y, NAITO I, OKIGAKI T: Transfer of anti-glomerular basement membrane antibody-induced glomerulonephritis in inbred rats with isologous antibodies from the urine of nephritic rats. J Pathol 158: 325-332, 1989
5. NISHIKAWA K, GUO Y-J, MIYASAKA M, TAMATANI T, COLLINS BA, SY M-S, MCCOLUSKE RT, ANDRES G: Antibodies to intercellular adhesion molecule I/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis. J Exp Med 177:667-677, 1993
6. BOUTON KW, MAY WJ, STURGILL BC: Proliferative autoimmune glomerulonephritis in rats: A model for autoimmune glomerulonephritis in humans. Kidney Int 44:294-306, 1993
7. WIESLANDER J, BARR JF, BUTKOWSKI RJ, EDWARDS SJ, BYGREN P. HELNEGARD D. HUDSON BG: Goodpasture antigen of the glomerular basement membrane: Localization to noncollagenous regions of type IV collagen, Proc Natl Acad Sci USA 81:3838-3842. 1984
8. WIESLANDER J, LANGEVELD J, BUTKOWSKI R, JODLOWSKI M, NOFLKEN M, HUDSON BG: Physical and immunochemical studies of the globular domain of type IV collagen. Cryptic properties of the Goodpasture antigen. J Biol Chem 260:8564-8570, 1985
9. HUDSON BG, WIESLANDER J, WISDOM BJ Jr, NOELken ME: Biology of Disease. Goodpasture syndrome: Molecular architecture and function of basement membrane antigen. Lab Invent 61:256-269, 1989
10. KALLURI R, GUNWAR S, REEDERS ST, MORRISON KC, MARIYAMA M, EBNER KE. NOELKIN ME. HUDSON BG: Goodpasture syndrome: Localization of the epitope for the autoantibodies to the carboxylterminal region of the α3(IV) chain of basement membrane collagen. J Biol Chem 266:24018-24024, 1991
11. KALLURI R, GATTONE VH, NOELKEN ME, HUDSUN BG: The α3 chain of type IV collagen induces autoimmune Goodpasture syndrome. Proc Natl Acad Sci USA 91:6201-6205, 1994
12. KRONENBERG M: Self-tolerance and autoimmunity. Cell 65:537-542, 1991
13. KAPPLER J, ROEHM N, MARRACK P: T cell tolerance by clonal elimination in the thymus. Cell 49:273-280, 1987
14. SPRENT J, LO D, GAO E-K, RON Y: T cell selection in the thymus. Immunol Rev 101:173-190, 1988
15. ELLISON GW, WAKSMAN BH: The role of the thymus in tolerance. IX. Inhibition of experimental autoallergic encephalomyelitis by intrathymic injection of encephalitogen. J Immunol 105:322-326, 1970
16. Goss JA, NAKAFUSA Y, ROLAND CR, HICKEY WF, FLYE WM: Immunological tolerance to a defined myelin basic protein antigen administered intrathymically. J Immunol 153:3890-3898, 1994
17. KHOURY SJ, SAYEGH MH, HANCOCK WW, GALLON L, CARPENTER CB, WEINER HL: Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide. J Exp Mad 178:559-566, 1993
18. KOEVARY SB, BLOMBERG M: Prevention of diabetes in BB/Wor rats by intrathymic islet injection. J Clin Invest 89:512-516, 1992
19. POSSEET AM, BARKER CF, FRIEDMAN AL, NAJI A: Prevention of autoimmune diabetes in the BB rat by intrathymic islet transplantation at birth. Science 256:1321-1324, 1992
20. GERLING I, SERREZE D, CHRISTIANSION S, LETTER E: Intrathymic islet cell transplantation reduces β-cell autoimmunity and prevents diabetes in NOD/Lt mice. Diabetes 41:1672-1676, 1992
21. HEROLD KC, MONTAG AG, BUCKINGHAM F: Induction of tolerance to autoimmune diabetes with islet antigens. J Exp Med 176:1107-1114, 1992
22. KALLURI R, SUN MJ, HUDSON BG, NELLSON EG: Goodpasture autoantigen: Structural delineation of two immunologically privileged epitopes on the α3 chain of type IV collagen. J Biol Chem 271:9062-9068, 1996
23. LANGEVELD JPM, WIESLANDER J, TIMONEDA J, MCKINNEY P, BUTKOWSKI RJ, WISDOM BJ, HUDSON BG: Structural heterogeneity of the noncollagenous domain of basement membrane collagen. J Biol Chem 263:10481-10488, 1988
24. KALLURI R, WILSON CB, WEBER M, GUNWAR S, CHONKO AM, NEILSON EG, HUDSON BG: Identification of α3 chain of type IV collagen as the common autoantigen in anti-GBM disease and Goodpasture syndrome. J Am Soc Nephrol 6:1178-1185, 1995
25. KALLURI R, MELENDEZ E, RUMPF WK, SATTLER K, MULLER GA, STRUTZ F, NEILSON EG: Specificity of circulating and tissue-bound autoantibodies in Goodpasture syndrome. Proc Assoc Am Phys 108: 1-6, 1996
26. BUTKOWSKI RJ, LANGEVELD JPM, WIESLANDER J, HAMILTON J, HUDSON BG: Localization of the Goodpasture epitope to a novel chain of basement membrane collagen. J Biol Chem 262:7874-7877, 1987
27. READ SM, NORTHCOTE DH: Minimization of variation in the response to different proteins of the Coomassie blue G-dye binding assay for protein., Anal Biochem 116:53-64, 1981
28. WOODROFFE AJ, WILSON CB: An evaluation of elution techniques in the study of immune complex glomerulonephritis. J Immunol 118: 1788-1794, 1977
29. GUNWAR S, BALLESTER F, KALLURI R, TIMONEDA J, CHONKO CM, EDWARDS S, NOELKEN ME, HUDSON BG: Glomerular basement membrane: Identification of the dimeric subunits of the non-collagenous domain (Hexamer) of collagen IV and the Goodpasture antigen. J Biol Chem 266:15318-15324, 1991
30. NEILSON EG, KALLURI R, SUN MJ, GUNWAR S, DANOFF T, MARIYAMA M, MYERS JC, REEDERS ST, HUDSON BG: Specificity of Goodpasture autoantibodies for the recombinant noncollagenous domains of human type IV collagen. J Biol Chem 268:8402-8405, 1993
31. LERNER RA, GLASSOCK RJ, DIXON FJ: The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med 126:989-1004, 1967
32. KARNOVSKY MJ: Formaldehyde-glutaraldehyde fixative of high osmolarity for use in electronmicroscopy. (abstract) J Cell Biol 27:137A, 1965
33. WICK G, VON DER MARK H, DIETRICH H, TIMPL R: Globular domain of basement membrane collagen induces autoimmune pulmonary lesions in mice resembling human Goodpasture disease. Lab Invest 55:308-317, 1986
34. BOLTON WK, LUO A-M, Fox P, MAY W, FOX J: Goodpasture's epitope in development of experimental autoimmune glomerulonephritis in rats. Kidney Int 49:327-334, 1996
35. SADO Y, BOUTAUD A, KAGAWA M, NAITO I, NINOMIYA Y, HUDSON BG: Induction of anti-GBM nephritis in rats by recombinant α3(IV)NC1 and α4(IV) NC1 of type IV collagen. Kidney Int 53:664-671, 1998
36. DOWNIE GH, ROHOLT OA, JENNINGS L, BIAU M, BRENTJFNS JR, ANDRES GA: Experimental anti-alveolar basement membrane antibody-mediated pneumonitis. II. Role of endothelial damage and repair, induction of autologous phase, and kinetics of antibody deposition in Lewis rats. J Immunol 129:2647-2652, 1982
37. JENNIGS L, ROHOLT OA, PRESSMAN D, BIAU M, ANDRES GA, BRENTJENS JR: Experimental anti-alveolar basement membrane antibody-mediated pneumonitis. I. The role of increased permeability of the alveolar capillary wall induced by oxygen. J Immunol 127:129-134, 1981
38. SALANT DJ: Immunopathogenesis of crescentic glomerulonephritis and lung purpura. Kidney Int 32:408-425, 1987
39. ZIMMERMAN SW, GROEHLER K, BEIRNE G: Hydrocarbon exposure and chronic glomerulonephritis. Lancet 2:199-201, 1975
40. DONAGHY M, REES AJ: Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane. Lancet 2:1390-1392, 1983
41. QUELUZ TH, PAWLOWSKI I, BRUNDA MJ, BRENTJENS JR, VLADUTIU AO, ANDRES G: Pathogenesis of an experimental model of Goodpasture's hemorrhagic pneumonitis. J Clin Invest 85:1507-1515, 1990
42. 2 receptor blocking abrogates donor-specific unresponsiveness to renal allografts triggered by thymic recognition of histocompatibility allopeptides. J Exp Med 180:1967-1972, 1994
43. KALLURI R, DANOFF TM, OKADA H, NEILSON EG: Susceptibility to anti-glomerular basement membrane disease and Goodpasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice. J Clin Invest 100:2263-2275, 1997
44. OHTSURU I, MATSUO H, FUKUDOME T, SUENAGA A, TSUJIHATA M, NAGATAKI S: 'Split tolerance' induction by intrathymic injection of acetylcholine receptor in a rat model of autoimmune myasthenia gravis; implications for the design of specific immunotherapies. Clin Exp Immunol 102:462-467, 1995
45. BONOMO A, MATZINGER P: Thymus epithelium induces tissue-specific tolerance. J Exp Med 177:1153-1164, 1993
46. RANSOM J, WU R, FISCHER M, ZLOTNIK A: Antigen presenting ability of thymic macrophages and epithelial cells: Evidence for defects in the antigen processing function of thymic epithelial cells. Cell Immunol 134:180-190, 1991
47. 1 bone marrow chimeras prepared with supraletal irradiation. J Exp Med 171:1101-1121, 1990
48. SPEISER DE, LEES RK, HENGARTNER H, ZINKERNAGEL RM, MACDONALD HR: Positive and negative selection of T cell receptor Vβ domains controlled by distinct cell populations in the thymus. J Exp Med 170:2165-2170, 1989
49. OLUWOLE SF, JIN M-X, CHOWDHURY NC, OHAJEKWE OA: Effectiveness of intrathymic inoculation of soluble antigens in the induction of specific unresponsiveness to rat islet allografts without transient recipient immunosuppression. Transplantation 58:1077-1081, 1994
50. BOREL Y, FAUCONNET M, MIESCHER PA: Selective suppression of delayed hypersensitivity by the induction of immunological tolerance. J Exp Med 123:585-598. 1996
51. CHILLER JM, HABICHT GS, WEIGLE WO: Kinetic differences in unresponsiveness of thymus and bone marrow cells. Science 171:813-815, 1971
52. RAJEWSKY K, BRENIG C: Paralysis to serum albumins in T and B lymphocytes in mice: Dose dependence, specificity and kinetics of escape. Eur J Immunol 4:120-125, 1974
53. BURNSTEIN HJ, SHEA CM, ABBAS AK: Aqueous antigens induce in vivo tolerance selectivity in IL-2 and IFN-gamma-producing (Th1) cells. J Immunol 148:3687-3691, 1992
54. KAGNOFF MF: Effects of antigen-feeding on intestinal and systemic immune responses II. Suppression of delayed-type hypersensitivity reactions. J Immunol 120:1509-1513, 1978
55. CHALLACOMBE SJ, TOMASI TB: Systemic tolerance and secretory immunity after oral immunization. J Exp Med 153:1459-1472, 1980
56. HUSBY S, MESTECKY J, MOLDOVEANU Z, HOLLAND S, ELSON CO: Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J Immunol 152:4663-4670, 1994